Compare OSUR & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSUR | HCAT |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.2M | 174.0M |
| IPO Year | 1986 | 2019 |
| Metric | OSUR | HCAT |
|---|---|---|
| Price | $2.40 | $2.35 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 11 |
| Target Price | $3.00 | ★ $4.30 |
| AVG Volume (30 Days) | ★ 742.3K | 736.0K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $125,703,000.00 | ★ $316,063,000.00 |
| Revenue This Year | N/A | $3.23 |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.63 |
| 52 Week Low | $2.08 | $2.02 |
| 52 Week High | $4.22 | $7.65 |
| Indicator | OSUR | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 39.20 |
| Support Level | $2.41 | $2.33 |
| Resistance Level | $2.53 | $2.51 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 15.52 | 6.13 |
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.